Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort
(MedPage Today) -- Stroke patients treated with intravenous alteplase (Activase) did not have more intracranial hemorrhages if they had recently taken non-vitamin K antagonist oral anticoagulants (NOACs), according to an Asian cohort study that...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Activase | Bleeding | Cardiology | Cardiovascular | Heart | Stroke | Study | Vitamin K | Vitamins